Status:

COMPLETED

Randomized Study of Anular Repair With the Xclose Tissue Repair System

Lead Sponsor:

Anulex Technologies, Inc.

Conditions:

Diskectomy

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the benefits of anulus fibrosus repair utilizing Xclose™ compared to a discectomy without anulus fibrosus repair.

Detailed Description

Discectomy surgery is intended to remove the impinging fragment on the nerve root thus alleviating the pain and providing the nerve with a better healing environment. Discectomy procedures entail remo...

Eligibility Criteria

Inclusion

  • Candidate for a one or two level discectomy
  • Positive imaging evidence of intervertebral disc herniation at location corresponding to patient's radicular signs or symptoms
  • Anular tear or slit incision and additionally deemed to include sufficient tissue for tissue reapproximation
  • Persistent and predominant radicular pain
  • Pre-operative leg pain score \> 4.0 cm on a 10 cm Visual Analog Scale (VAS)
  • Leg pain unresponsive to conservative treatment (physical therapy and non-steroidal anti-inflammatory medical therapy) for 6 or more weeks; exception, individuals suffering from acute and uncontrollable severe leg pain
  • Patient is willing and able to comply with study requirements; willing and able to sign a study-specific, informed consent form, complete necessary study paperwork and return for required follow-up visits.

Exclusion

  • Age less than 18 years
  • Prior or planned surgical procedure intended to fuse or stabilize the lumbar spine
  • Previous surgery involving index level
  • Cauda Equina Syndrome
  • Evidence of severe disc degeneration
  • Greater than Grade I spondylolisthesis or retrolisthesis at the affected level
  • No apparent anular defect and no indication to open the anulus at time of procedure
  • Active local or systemic infection
  • Active malignancy or other significant medical co-morbidities
  • Current chemical dependency or significant emotional and/or psychosocial disturbance that would impact treatment outcome or study participation
  • Patient or legal guardians who are unwilling or unable to cooperate or give written informed consent
  • Women who are pregnant or with child bearing potential and who are not on a reliable form of birth control
  • Current fracture, tumor and/or deformity (\> 15° of lumbar scoliosis, using Cobb measuring technique) of the spine
  • Documented history of allergy or intolerance to PET
  • Patient is currently enrolled in other research that could confound the results of the study.

Key Trial Info

Start Date :

March 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2012

Estimated Enrollment :

750 Patients enrolled

Trial Details

Trial ID

NCT00760799

Start Date

March 1 2007

End Date

January 1 2012

Last Update

May 2 2012

Active Locations (34)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (34 locations)

1

North Alabama Neurological, P.A.

Huntsville, Alabama, United States, 35801

2

Texas Back Institute

Phoenix, Arizona, United States, 85015

3

Desert Institute for Spine Care

Phoenix, Arizona, United States, 85020

4

University of California San Diego

San Diego, California, United States, 92103